Major adverse cardiovascular events in Sjögren’s disease: incidence, associated factors, and impact on mortality in a prospective multicenter cohort
Rheumatology International · 01.06.2026 · 46 (6)
DOI: 10.1007/s00296-026-06138-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Rheumatology International, online erschienen am 01.06.2026. Verfasst von Olga Rusinovich-Lovgach und 34 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology department, Puerta de Hierro Majadahonda University Hospital, Calle Manuel de Falla, 1, Majadahonda, 28222, Madrid, Spain. olga_2011@yah…. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Stroke, Myocardial Infarction, Cardiovascular Diseases. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Sociedad Española de Reumatología.
Abstract (Originalsprache)
To determine incidence of major adverse cardiovascular events (MACE: non-fatal myocardial infarction, non-fatal stroke, or cardiovascular death) in Sjögren's disease (SjD); identify traditional and disease-specific factors associated with MACE; describe prevalence of cardiovascular risk factors (CVRFs); explore, descriptively, SCORE2-estimated risk by comparing predicted and observed events; estimate cardiovascular mortality; and assess association between MACE and all-cause mortality. Prospective, multicenter cohort study including 314 patients fulfilling 2002 AECG criteria for SjD, followed for median 9.5 years. Clinical, serological, and cardiovascular data were recorded. Factors associated with MACE were evaluated using multivariable logistic regression models. SCORE2 risk was calculated in patients with complete data, and expected events were compared with observed events. Cardiovascular mortality was expressed as crude rates per 1,000 patient-years. Seventeen patients (5.41%) developed MACE: 7 strokes (2.23%), 5 myocardial infarctions (1.59%), and 5 cardiovascular deaths (1.59%). Twelve additional non-MACE cardiovascular events were recorded. In a complete-case SCORE2 analysis including 130 patients, 5.74 events (4.41%) were predicted and 6 (4.62%) observed. In exploratory multivariable analysis, factors associated with MACE were age (OR 1.09), cryoglobulinemia (OR 10.42), and glucocorticoid use (OR 3.61). CVRFs were common, particularly dyslipidemia (33.1%) and hypertension (26.4%). Crude cardiovascular mortality rate was 1.8 per 1,000 patient-years. MACE was associated with higher all-cause mortality in a relative risk analysis (RR 3.49). MACE affected approximately 5% of patients and was associated with a threefold increase in all-cause mortality. Cryoglobulinemia and glucocorticoids were associated with MACE in multivariable analysis. In exploratory complete-case analysis, SCORE2 showed numerical concordance for atherosclerotic events but did not capture disease-specific risk. These findings support tailored cardiovascular risk assessment and prevention strategies in SjD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rheumatology department, Puerta de Hierro Majadahonda University Hospital, Calle Manuel de Falla, 1, Majadahonda, 28222, Madrid, Spain. olga_2011@yahoo.com.
- Research Unit, Spanish Society of Rheumatology, Madrid, Spain.
- Rheumatology department, Puerta de Hierro Majadahonda University Hospital, Calle Manuel de Falla, 1, Majadahonda, 28222, Madrid, Spain.
- School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
- Rheumatology department, Marina Baixa de La Vila Joiosa Hospital, Alicante, Spain.
- Marqués de Valdecilla University Hospital, Immunopathology Group, IDIVAL, Santander, Spain.
ORCID-Profile: Zulema Plaza, José Luis Andréu, José Rosas, Victor M Martínez Taboada, Judit Font-Urgelles, Ángel Garcia-Aparicio, Sara Manrique-Arija, Jesús Alberto Garcia Vadillo, Ruth Lopez-Gonzalez, Javier Narváez, Mª Beatriz Rodriguez Lozano, Jorge Juan Gonzalez Martin, Paloma Vela-Casasempere, Mª Beatriz Paredes Romero, Sheila Melchor Diaz, Sergi Heredia, Boris Blanco Cáceres, Paula Estrada-Alarcón, Enrique Judez, Fernando Sánchez Alonso, Mónica Fernández Castro
Förderung
- Sociedad Española de Reumatología
Zitieren
APA
Rusinovich-Lovgach, O., Plaza, Z., Andréu, J. L., Rosas, J., Taboada, V. M. M., Olive, A., Almagro, R. M., Benavente, B. S., Font-Urgelles, J., Garcia-Aparicio, Á., Manrique-Arija, S., Vadillo, J. A. G., Lopez-Gonzalez, R., Narváez, J., Lozano, M. B. R., Galisteo, C., Martin, J. J. G., Vela-Casasempere, P., Bohorquez, C., …, & SJÖGRENSER PROS Group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER) (2026). Major adverse cardiovascular events in Sjögren’s disease: incidence, associated factors, and impact on mortality in a prospective multicenter cohort. Rheumatology International, 46(6). https://doi.org/10.1007/s00296-026-06138-9
Vancouver
Rusinovich-Lovgach O, Plaza Z, Andréu JL, Rosas J, Taboada VMM, Olive A, et al. Major adverse cardiovascular events in Sjögren’s disease: incidence, associated factors, and impact on mortality in a prospective multicenter cohort. Rheumatology International. 2026;46(6). doi:10.1007/s00296-026-06138-9
BibTeX
@article{RusinovichLovgach2026,
author = {Rusinovich-Lovgach, Olga and Plaza, Zulema and Andréu, José Luis and Rosas, José and Taboada, Victor M Martínez and Olive, Alejandro and Almagro, Raúl Menor and Benavente, Belén Serrano and Font-Urgelles, Judit and Garcia-Aparicio, Ángel and Manrique-Arija, Sara and Vadillo, Jesús Alberto Garcia and Lopez-Gonzalez, Ruth and Narváez, Javier and Lozano, Mª Beatriz Rodriguez and Galisteo, Carlos and Martin, Jorge Juan Gonzalez and Vela-Casasempere, Paloma and Bohorquez, Cristina and Erausquin, Celia and Romero, Mª Beatriz Paredes and Riancho-Zarrabeitia, Leyre and Diaz, Sheila Melchor and Altabás, Irene and Heredia, Sergi and Moriano, Clara and Cáceres, Boris Blanco and Estrada-Alarcón, Paula and Judez, Enrique and Belzungui, Joaquín and Loricera, Javier and Ramos, Consuelo and Alonso, Fernando Sánchez and Castro, Mónica Fernández and SJÖGRENSER PROS Group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER), SJÖGRENSER PROS Group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER)},
title = {Major adverse cardiovascular events in Sjögren’s disease: incidence, associated factors, and impact on mortality in a prospective multicenter cohort},
journal = {Rheumatology International},
year = {2026},
volume = {46},
number = {6},
doi = {10.1007/s00296-026-06138-9}
}
EUVIMED